Shockwave Therapy Clinical Evidence

Wheeler 2022 | Gr. Trochanteric Pain | RSW

Back to overview

Wheeler PC, Dudson C, Calver R, Goodall D, Gregory KM, Singh H, Boyd KT. Three Sessions of Radial Extracorporeal Shockwave Therapy Gives No Additional Benefit Over "Minimal-Dose" Radial Extracorporeal Shockwave Therapy for Patients With Chronic Greater Trochanteric Pain Syndrome: A Double-Blinded, Randomized, Controlled Trial. Clin J Sport Med. 2022 Jan 1;32(1):e7-e18.

Double-blinded randomised controlled trial. 120 subjects who had no improvement with 3m standard rehab. Subjects were randomised to 2 groups who received RSW treatment with Chattanooga Intelect RPW • Group 1. 3 sessions 2000 shocks 2.3-3.3 bar (max tolerable) • Group 2. 3 sessions 500 shocks 1.4 bar Results Both groups showed significant improvements in hip pain and function scores with no significant difference between the groups.

Key message 500 pulses @ 1.4 bar ("minimal dose") RSW treatment provided significant improvement of pain and PROM in GTPS. More shocks and higher pressure did not provide additional benefit.

iEnovis

Pubmed

Figures

43

© 2022 Enovis Corporation

CONFIDENTIAL

Made with FlippingBook - PDF hosting